Furthermore, biomarkers such as TTF-1 and CDX-2 can be used to identify metastatic MCC, whereas LCA, CD99, S100, HMB-45, and SOX-10 can exclude lymphoma, Ewing sarcoma, and malignant melanoma. Here, CDX2 is linked to lymphoma.